Drug intelligence / Profile preview

epoetin theta

Development stage: Unknown
Lead developer: Teva Pharmaceutical Industries
Modality: Recombinant Proteins and Enzymes
Administration: Subcutaneous, Intravenous

Overview

Epoetin theta is a **recombinant human erythropoietin** produced in Chinese Hamster Ovary (CHO-K1) cells using recombinant DNA technology. It is a biologic drug indicated for the treatment of **symptomatic anaemia associated with chronic renal failure in adult patients** and for **symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy**. Epoetin theta acts by stimulating erythropoiesis (red blood cell production) through promoting the survival, proliferation, and differentiation of erythroid progenitors in the bone marrow, mimicking the physiological activity of endogenous erythropoietin. It has a comparable safety and efficacy profile to other erythropoietin products and is administered either subcutaneously or intravenously, with dosing tailored to the clinical context[1][2][3][5][7].

Brand names: EporatioBiopoin
Other names: recombinant human erythropoietin theta

Targets

Erythropoietin Receptor

Beyond the preview

Go deeper on epoetin theta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on epoetin theta.

Explore the full profile